Green Claire E, Albaba Shadi, Sobey Glenda J, Bowen Jessica M, Donnelly Deirdre E, Colombi Marina, Ritelli Marco, Melville Athalie, Ghali Neeti, van Dijk Fleur S, Hobson Emma, Radley Jessica A, Kinning Esther, Dixit Abhijit, McCullough Simon, Baker Duncan, Johnson Diana S
Ehlers-Danlos Syndrome National Diagnostic Service, Sheffield Children's Hospital, OPD2, Northern General Hospital, Sheffield, UK.
Sheffield Diagnostic Genetics Service, Sheffield, UK.
Eur J Hum Genet. 2025 Apr 17. doi: 10.1038/s41431-025-01849-2.
Interstitial deletions of 2q32 are typically identified after investigation for developmental delay. Two genes associated with Ehlers Danlos Syndrome (EDS); COL3A1 and COL5A2 associated with vascular EDS and classical EDS respectively, may be incorporated in the region. Although many reports of 2q32 microdeletion patients exist, there is little mention of these genes with only a few reports highlighting features potentially linked with EDS. This paper reviews the literature and presents eleven new patients with 2q32 deletions that encompass COL3A1 and COL5A2. We describe their clinical manifestations with a particular focus on the EDS phenotype. Most patients showed some minor features of vascular EDS and one patient had vessel rupture at a young age. Analysis of skin biopsy findings from two patients showed features consistent with vascular EDS but no features of classical EDS. The findings from this cohort provide additional evidence that haploinsufficiency is an important disease mechanism in COL3A1 but not COL5A2. We highlight the importance of pre-test counselling for incidental findings from broad genetic testing and appropriate post-test counselling to ensure follow up is provided to manage the implications of a vascular EDS diagnosis.
2q32间质性缺失通常是在对发育迟缓进行调查后发现的。与埃勒斯-当洛综合征(EDS)相关的两个基因,即分别与血管型EDS和经典型EDS相关的COL3A1和COL5A2,可能包含在该区域。虽然有许多关于2q32微缺失患者的报道,但很少提及这些基因,只有少数报道强调了可能与EDS相关的特征。本文回顾了文献,并介绍了11例包含COL3A1和COL5A2的2q32缺失的新患者。我们描述了他们的临床表现,特别关注EDS表型。大多数患者表现出一些血管型EDS的轻微特征,一名患者在年轻时出现血管破裂。对两名患者皮肤活检结果的分析显示出与血管型EDS一致的特征,但没有经典型EDS的特征。该队列的研究结果提供了额外的证据,表明单倍剂量不足是COL3A1而非COL5A2的重要疾病机制。我们强调了针对广泛基因检测中的偶然发现进行检测前咨询以及进行适当的检测后咨询的重要性,以确保提供后续跟进措施来处理血管型EDS诊断的影响。